硫酸氢氯吡格雷、阿托伐他汀、阿司匹林三联治疗急性脑梗死的临床

硫酸氢氯吡格雷、阿托伐他汀、阿司匹林三联治疗急性脑梗死的临床效果及安全性分析

http://www.100md.com 2025年8月13日医学信息 2025年第14期

    中图分类号：R743.33 文献标识码：A文章编号：1006-1959(2025)14-0081-05

    DOI：10.3969/j.issn.1006-1959.2025.14.014

    AbstractObeieetdedslassat ofacuteerebralifarctioMetdsTtallOatitsitutecerealfarctiodmiedtWan'anoutyeolessitalfroJ 2021toJanuary24eredvidedntocontrolgroundudygoupusingthdomumbertableethodwith4atintsiachoupe controlgroupastreatedispcoatdblesobdittoastatiabletsndtesudouarateditode isulfateablesisfoaloddeaoleslC)glde)i lipopoteinll atherosclerosisarotidaeditcknss(laqeicks，laqeedplaqeberndcideneofdeo (headachesse study group (95.00 % )washigher than that inthe control group (72.50 % )(Plt;0.05).After treatment，the levelsofTC，TGandLDL-Cinthe two groups werelowerthaosebeforetreatent，televelofDL-Cwashigeranthatborereatenteanileompaedwithteotrolgroupte levelsofTC，TGandLDL-Cinthestudygroup wereloweraftertreatment，whilethelevelofHDL-Cwashigher( Pe lt;0.05).The NIHSSscore of the twogroupsaferreaetaslowertantatforereaetteDsoasertanthatereaeteailompadwihthe control group，the NIHSS score of the study group after treatment was lower ......

百拇医药网 http://www.100md.com/html/paper/1006-1959B/2025/14/011.htm

您现在查看是摘要页，全文长 14479 字符。